Oncology Product Guide » Lung Cancer

Agennix Expands Talactoferrin Phase 3 FORTIS-M Registration Trial Globally

Jim Marino — Fri, 22 Jan 2010 04:19:42 +0000

Agennix Expands Talactoferrin Phase 3 FORTIS-M Registration Trial Globally Agennix AG announced that the next stage of the FORTIS-M trial has begun, with the first patient being dosed in Europe. FORTIS-M is a Phase 3 registration trial evaluating oral talactoferrin versus placebo in advanced non-small cell lung cancer (NSCLC) in patients whose disease has progressed following two or more prior therapies. The trial is expected to enroll approximately 720 patients.

For the full story, Click Here

Alimta approved by FDA

Jim Marino — Thu, 16 Jul 2009 07:31:17 +0000

The FDA has approved Alimta, the first drug for maintenance therapy of advanced or metastatic lung cancer. Manufactured by Eli Lilly and generically known as pemetrexed, this drug may prevent this form of lung cancer from progressing further after the size of the tumor has shrunk or been stabilized following chemotherapy. Alimta works by disrupting metabolic processes which depend on the B-vitamin folate for cell replication.

Blood Scanner That Detects Even Faint Indicators Of Cancer Developed By Stanford Researchers

Jim Marino — Wed, 17 Dec 2008 12:17:54 +0000

A team led by Stanford University researchers has developed a prototype blood scanner that can find cancer markers in the bloodstream in early stages of the disease, potentially allowing for earlier treatment and dramatically improved chances of survival. The system based on MagArray biodetection chips can find cancer-associated proteins in a blood serum sample in less than an hour. This could be especially helpful for lung cancer, ovarian cancer and pancreatic cancer, because those cancers are hidden in the body

Biologics offers Hycamtin for cancer treatment

Jim Marino — Tue, 30 Sep 2008 05:26:21 +0000

Biologics, Inc. has announced that a new oral medication for relapsed small cell lung cancer, Hycamtin (topotecan) Capsules, is now available through its oncology pharmacy. Doctors specializing in cancer treatment choose Biologics for dispensing prescriptions to their patients because as it offers clinical expertise in oncology and exceptional service. Biologics, Inc. helps patients, clinicians, manufacturers and researchers throughout the United States in management of cancer. The company’s expertise is in reimbursement, distribution and patient management. Its pharmacy has more than 60 drugs used in treating cancer.